These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 6323533)
1. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1. Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533 [TBL] [Abstract][Full Text] [Related]
2. Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant. Rall SC; Newhouse YM; Clarke HR; Weisgraber KH; McCarthy BJ; Mahley RW; Bersot TP J Clin Invest; 1989 Apr; 83(4):1095-101. PubMed ID: 2539388 [TBL] [Abstract][Full Text] [Related]
3. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype. Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. Wardell MR; Brennan SO; Janus ED; Fraser R; Carrell RW J Clin Invest; 1987 Aug; 80(2):483-90. PubMed ID: 3038959 [TBL] [Abstract][Full Text] [Related]
5. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype. Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898 [TBL] [Abstract][Full Text] [Related]
6. Identification, molecular characterization, and cellular studies of an apolipoprotein E mutant (E1) in three unrelated families with hyperlipidemia. Miller DB; Hegele RA; Wolfe BM; Huff MW J Clin Endocrinol Metab; 1995 Mar; 80(3):807-13. PubMed ID: 7883834 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes. Weisgraber KH; Newhouse YM; Taylor JM; Tuan B; Nestruck AC; Davignon J; Mahley RW Arteriosclerosis; 1989; 9(1):50-7. PubMed ID: 2912421 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502 [TBL] [Abstract][Full Text] [Related]
9. Molecular basis of type III hyperlipoproteinemia in Germany. Feussner G; Feussner V; Hoffmann MM; Lohrmann J; Wieland H; März W Hum Mutat; 1998; 11(6):417-23. PubMed ID: 9603433 [TBL] [Abstract][Full Text] [Related]
10. Characterization of an apolipoprotein E3 variant (Arg 145-->His) associated with mild hypertriglyceridemia. Hidaka H; Tozuka M; Hidaka E; Yamauchi K; Ota H; Honda T; Katsuyama T Ann Clin Lab Sci; 2001 Apr; 31(2):163-70. PubMed ID: 11337906 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E phenotype affects the malondialdehyde-modified LDL concentration and forearm endothelial function in postmenopausal women. Tsuda M; Sanada M; Higashi Y; Hara Y; Kodama I; Chayama K; Yoshizumi M; Ohama K Clin Endocrinol (Oxf); 2004 Nov; 61(5):619-25. PubMed ID: 15521966 [TBL] [Abstract][Full Text] [Related]
12. Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels. Horita K; Eto M; Saito M; Nakata H; Iwashima Y; Ito H; Takahashi M; Kondo A; Morikawa A; Makino I Artery; 1993; 20(6):324-36. PubMed ID: 8010888 [TBL] [Abstract][Full Text] [Related]
13. A novel apolipoprotein E5 variant with a 24-bp insertion causing hyperlipidemia. Yamanouchi Y; Takano T; Hamaguchi H; Tokunaga K J Hum Genet; 2001; 46(11):633-9. PubMed ID: 11721882 [TBL] [Abstract][Full Text] [Related]
14. [Pathology of the human apolipoprotein E gene]. Iron A; Richard P; Beucler I; Thomas G; Pascual de Zulueta M; Bereziat G; Cassaigne A; de Gennes JL Bull Acad Natl Med; 1994 Mar; 178(3):415-26. PubMed ID: 8076181 [TBL] [Abstract][Full Text] [Related]
15. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations. Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050 [TBL] [Abstract][Full Text] [Related]
16. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. Horie Y; Fazio S; Westerlund JR; Weisgraber KH; Rall SC J Biol Chem; 1992 Jan; 267(3):1962-8. PubMed ID: 1730728 [TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of apolipoprotein E: a variant form of apolipoprotein E2 distinguished by sodium dodecyl sulfate--polyacrylamide gel electrophoresis. Utermann G; Weisgraber KH; Weber W; Mahley RW J Lipid Res; 1984 Apr; 25(4):378-82. PubMed ID: 6726088 [TBL] [Abstract][Full Text] [Related]
19. Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 type. Menzel HJ; Assmann G; Rall SC; Weisgraber KH; Mahley RW J Biol Chem; 1984 Mar; 259(5):3070-6. PubMed ID: 6421816 [TBL] [Abstract][Full Text] [Related]
20. In vivo alteration of a mutant human protein using the free thiol cysteamine. Gahl WA; Gregg RE; Hoeg JM; Fisher E Am J Med Genet; 1985 Feb; 20(2):409-17. PubMed ID: 3976729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]